Interview: Charles Ng – Associate Director-General; Simon Tsang – Head of Innovation and Technology, InvestHK, Hong Kong

Charles Ng and Simon Tsang of InvestHK, Hong Kong’s investment promotion agency, discuss the territory’s strengths in the life sciences sector, the potential of the HK industry to grow further, and its regional significance. The Swiss-based International Institute for Management Development (IMD) recently placed Hong Kong at the top of its 2017 World Competitiveness Rankings, overtaking countries like Switzerland, Singapore and the US. From your perspective, how does this reflect Hong Kong’s strengths in the healthcare and life sciences sector?
"Hong Kong is in a sweet spot because we are part of the world’s second largest economy. Under the ‘One Country, Two systems’ approach, we have the best of both worlds."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report